Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anna G Turkina (A G Turkina, Anna Turkina)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Leukemia

Terapevticheskii arkhiv

BMC medical genomics

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia (2023)
Ekaterina Yu Chelysheva, A N Petrova, Oleg A Shukhov, A V Bykova, I S Nemchenko, M A Gurianova, N N Tsyba, Anna G Turkina
[Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia]. Terapevticheskii arkhiv 94 (7) (2022)
Timothy P Hughes, Nelma Cristina D Clementino, Mikhail Fominykh, Jeffrey H Lipton, Anna G Turkina, Elena Beatriz Moiraghi, Franck E Nicolini, Naoto Takahashi, Tomasz Sacha, Dong-Wook Kim, Rafik Fellague-Chebra, Ranjan Tiwari, Catherine Bouard, Francois-Xavier Mahon
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update. Leukemia 35 (6) (2021)
M A Gurianova, Ekaterina Yu Chelysheva, Oleg A Shukhov, Anna G Turkina
[Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review]. Terapevticheskii arkhiv 92 (7) (2020)
Markus Pfirrmann, Richard E Clark, Witold Prejzner, Michael Lauseker, Michele Baccarani, Susanne Saussele, François Guilhot, Sonja Heibl, Rüdiger Hehlmann, Edgar Faber, Anna G Turkina, Gert Ossenkoppele, Martin Höglund, Andrey Zaritskey, Laimonas Griskevicius, Ulla Olsson-Strömberg, Hele Everaus, Perttu Koskenvesa, Boris Labar, Tomasz Sacha, Daniela Zackova, Francisco Cervantes, Adriana Colita, Irena Zupan, Andrija Bogdanovic, Fausto Castagnetti, Joëlle Guilhot, Joerg Hasford, Andreas Hochhaus, Verena S Hoffmann
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia. Leukemia 34 (8) (2020)
Alexander V Lavrov, Ekaterina Yu Chelysheva, Elmira P Adilgereeva, Oleg A Shukhov, Svetlana A Smirnikhina, Konstantin S Kochergin-Nikitsky, Valentina D Yakushina, Grigory A Tsaur, Sergey V Mordanov, Anna G Turkina, Sergey I Kutsev
Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients. BMC medical genomics 12 (Suppl 2) (2019)
Svetlana A Smirnikhina, Ekaterina Yu Chelysheva, Alexander V Lavrov, Konstantin S Kochergin-Nikitsky, Ivan V Mozgovoy, Elmira P Adilgereeva, Oleg A Shukhov, Anna N Petrova, Anastasia V Bykova, Adhamjon O Abdullaev, Anna G Turkina, Sergey I Kutsev
Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation. Leukemia & lymphoma 59 (10) (2018)

Anna G Turkina.css-eqlu8i{font-size:small;padding-left:4px;} (A G Turkina, Anna Turkina)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna G Turkina (A G Turkina, Anna Turkina)